PP
ISEE

Paloma Partners’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Paloma Partners’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-26,281
Closed -$82K – 2335
2017
Q4 		$82K Buy
+26,281
New +$73.9K ﹤0.01% 1804
2017
Q3 		– Sell
-112,300
Closed -$287K – 2537
2017
Q2 		$287K Buy
+112,300
New +$306K ﹤0.01% 1818
2014
Q3 		– Sell
-30,000
Closed -$1.27M – 1360
2014
Q2 		$1.27M Buy
+30,000
New +$1.1M 0.05% 300

Other funds holding ISEE

Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Paloma Partners's ISEE Position: Q1 2018 in Review

Paloma Partners sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2018, closing a stake of 26,281 shares — an estimated $82K sold.

Paloma Partners first reported a position in ISEE in Q2 2014 and held it in 3 quarters. The position peaked at $1.27M in Q2 2014. 71 funds tracked by Wall St. Rank hold ISEE as of Q1 2018.

  • Paloma Partners reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Paloma Partners sold 26,281 IVERIC bio, Inc. Common Stock shares in Q1 2018, an estimated $82K.
  • Paloma Partners first reported a position in IVERIC bio, Inc. Common Stock in Q2 2014 and held it in 3 quarters.
  • Paloma Partners's IVERIC bio, Inc. Common Stock position peaked at $1.27M in Q2 2014.
  • 71 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2018.

Based on Paloma Partners's 13F filing for Q1 2018, filed 15 May 2018.